Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,190.00
+40.00 (1.86%)
Jan 9, 2026, 4:20 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 132.44 billion as of January 9, 2026. Its market cap has increased by 44.53% in one year.
Market Cap
132.44B
Enterprise Value
111.63B
Revenue
24.48B
Ranking
n/a
PE Ratio
13.46
Stock Price
2,190.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 132.44B, an increase of 3,494.77%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 132.44B | 6.07% |
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.65T |
| Coloplast | 127.06B |
| ALK-Abelló | 50.48B |
| Demant | 46.99B |
| H. Lundbeck | 42.88B |
| Zealand Pharma | 29.89B |
| Ambu A/S | 23.56B |
| GN Store Nord | 16.26B |